VARIABILITY OF THE LDL-C RESPONSE TO TWO INTENSIVE LIPID-LOWERING THERAPY REGIMENS IN PATIENTS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Li, Ya [1 ]
Jin, Jinhua [1 ]
Zhang, Wenbin [1 ]
机构：
[1] Sir Run Run Shaw Hosp, Biomed Res Therapy Ctr, Hangzhou, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] Lipid-lowering therapy in patients with a 'normal' LDL-C Authors' response
    Nelson, Adam
    Nicholls, Stephen
    AUSTRALIAN PRESCRIBER, 2024, 47 (03) : 94 - 94
  • [2] THE EFFECT OF AN INTENSIVE LIPID-LOWERING THERAPY PROTOCOL ON ACHIEVING TARGET LDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Seiyama, Kosuke
    Oka, Akihiro
    Takagi, Wataru
    Okada, Tomoaki
    Nosaka, Kazumasa
    Miyoshi, Toru
    Doi, Masayuki
    ATHEROSCLEROSIS, 2024, 395
  • [3] Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Lee, Seung-Jun
    Joo, Jae Hong
    Park, Sohee
    Kim, Choongki
    Choi, Dong-Woo
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Nam, Chung-Mo
    Hong, Myeong-Ki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 401 - 410
  • [4] Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy
    Aronow, HD
    Quinn, MJ
    Gurm, HS
    Topol, EJ
    Lincoff, M
    Brennan, DM
    Lauer, MS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 32A - 32A
  • [5] Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome
    Haider, P.
    Galli, L.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Krychtiuk, K.
    Speidl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S419 - S419
  • [6] Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a prospective Swiss cohort
    Gencer, B.
    Mach, F.
    Auer, R.
    Raeber, L.
    Nanchen, D.
    Meyer, P.
    Matter, C. M.
    Windecker, S.
    Luescher, T. F.
    Rodondi, N.
    EUROPEAN HEART JOURNAL, 2013, 34 : 136 - 136
  • [7] LDL-C variability was affected by lipid-lowering strategies and associated with adverse cardiovascular outcomes
    Kim, Dong-Eon
    Hong, Sung-Jin
    Bangalore, Sripal
    Yun, Kyeong Ho
    Lee, Sang-Hyup
    Lee, Yong-Joon
    Lee, Seung-Jun
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Hong, Bum
    Hong, Myeong-Ki
    CIRCULATION, 2024, 150
  • [8] The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention
    Ma, JM
    Jackevicius, CA
    Dzavik, V
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (05) : 419 - 423
  • [9] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
  • [10] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
12345